ArticleCell death & disease2025

Therapeutic targeting de novo purine biosynthesis driven by β-catenin-dependent PPAT upregulation in hepatoblastoma.

Ming Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.